openPR Logo
Press release

Ulcerative Colitis Market 2022 | Asia-Pacific registering a CAGR of 6.5%

07-13-2022 05:21 AM CET | Health & Medicine

Press release from: allied market research

Ulcerative Colitis Market 2022 | Asia-Pacific registering

Ulcerative Colitis Market by Disease Type (Mild UC, Moderate UC, Severe UC), by Molecule Type (Biologics, Small Molecules), by Route of Administration (Oral, Injectables): Global Opportunity Analysis and Industry Forecast, 2020-2030

According to a new report published by Allied Market Research, titled, "Ulcerative Colitis Market," The ulcerative colitis market was valued at $6.2 billion in 2020, and is estimated to reach $10.8 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030.

The impact of the COVID-19 pandemic on the ulcerative colitis market was reported to be negative, due to COVID-19, patients forced to postpone or cancel elective surgery, including elective procedures for inflammatory bowel disease (IBD), despite the higher risk of these patients of requiring urgent surgery. So, the delay the procedures of ulcerative colitis treatment decrease the production of medications over ulcerative colitis disease has restricted the growth of the market.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/3965

Key Market Players

ABBOTT LABORATORIES
AJINOMOTO CO. INC.
ASTRAZENECA PLC
ELI-LILLY
INDEX PHARMACEUTICALS HOLDINGS AB
GLAXOSIMITHKLINE PLC
JOHNSON & JOHNSON
Merck & Co. Inc.
Pfizer Inc.
SANOFI S.A

The global ulcerative colitis market is segmented on the basis of disease type, molecule type, route of administration, and region. On the basis of disease type, the market is fragmented into mild ulcerative colitis, moderate ulcerative colitis, and severe ulcerative colitis. The mild UC segment dominated the market in 2020, and this ulcerative colitis market trends is expected to continue during the forecast period, owing to increase in number of inflammatory bowel disease cases, advancements in R&D activities in pharmaceutical industries, and surge in adoption of ulcerative colitis drugs.

Ulcerative colitis is an inflammatory bowel disease that affects the colon of the human body. The disease affects people of any age and most commonly it begins during adolescence and early adulthood, but it may also occur later in life. Ulcerative colitis is highly prevalent in the U.S., England, and northern Europe. The most commonly preferred treatment options for ulcerative colitis are traditional medications made of biologics and small molecules.

Key Market Segments

By Disease Type
Mild UC
Moderate UC
Severe UC
By Molecule Type
Biologics
Small Molecules
By Route of Administration
Oral
Injectables

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3965

By molecule type, the market is divided into small molecules and biologics. The small molecule segment acquired top position in the ulcerative colitis industry in 2020, and this trend is expected to continue during the forecast period, owing to large number of drugs offered by key players and increase in use of drugs for the treatment of inflammatory gastrointestinal disorder. By route of administration, the market is fragmented into oral and injectables.

KEY FINDINGS OF THE STUDY

By disease type, the mild UC segment was the highest contributor to the market in 2020.
On the basis of molecule type, the small molecule segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
On the basis of route of administration, the oral segment dominated the market in 2020, and is expected to continue this trend during the forecast period
Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Request Customization: https://www.alliedmarketresearch.com/request-for-customization/3965

Contact:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Market 2022 | Asia-Pacific registering a CAGR of 6.5% here

News-ID: 2678163 • Views: 254

More Releases from allied market research

Activewear Market Global Trends, Size, Segments and Growth till 2024
According to a new report published by Allied Market Research titled, Activewear Market by Product and Fabric: Global Opportunity Analysis and Industry Forecast, 20172024," the global activewear market was valued at $ 351,164 million in 2017, and is expected to reach $ 546,802 million by 2024, registering a CAGR of 6.5 % from 2018 to 2024. North America dominated the global activewear market in 2017, accounting for 42.3% of the
Crunchy Chocolate Market Size, Trends, Share, Research Report Study, Regional an …
The global crunchy chocolate market was estimated at $16.86 billion in 2020 and is expected to hit $27.86 billion by 2030, registering a CAGR of 5.1% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. Request The Free Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/13997 High-end product innovation, rise in disposable income
Condensed milk Market Growing at 4.4% CAGR to Hit USD 15.2 Billion by 2031
The Condensed milk Market Size was valued at $9.9 billion in 2021, and is estimated to reach $15.2 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031. Milk without moisture is referred to as condensed milk. In other words, condensed milk is what we get when the milk's moisture is removed through evaporation. The same nutritional advantages of calcium, protein, magnesium, and other nutrients are present in
High-End Instant Noodles Market Size, Share, Industry Analysis and Global Foreca …
These are basically dried or precooked noodle blocks, which can be cooked in boiling water or can be reheated. It is the most popular convenience food consumed worldwide, as they are inexpensive and easy to prepare. They contain several micronutrients including iron, manganese, and vitamin B. Some of the popular brands of high-end instant noodles are Prima Laksa Lamian, Shin Ramyun Black, Mama Creamy Tom Yum, Myojo Ramen, and Omachi. Avail

All 5 Releases


More Releases for Ulcerative

Ulcerative Colitis Market to Reach $4,785 Million by 2023
Advancements in ulcerative colitis treatment modalities has led to the emergence of biologics such as tumor necrosis factors (TNF) in developing drugs. This has led to the shift from traditional therapies towards engineered drugs that has also enhanced the efficacy rate of drugs. According to a new report published by Allied Market Research, titled, Ulcerative Colitis Market by Disease Type, Route of Administration, and Molecule Type: Global Opportunity Analysis and Industry
Ulcerative Colitis Market to Obtain Awesome Hike in Revenues
Global ulcerative colitis market was valued at $4,785 million in 2016, and is expected to reach $7,455 million by 2023, registering a CAGR of 6.5% from 2017 to 2023. The mild ulcerative colitis disease type accounted for nearly half of the market share in 2016. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/3965 Ulcerative colitis is an inflammatory bowel disease that affects the colon and rectum of the human body. The disease
Ulcerative Colitis Market - Global Industry Analysis, Size, Forecast 2028
Ulcerative Colitis Market “Ulcerative Colitis-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Ulcerative Colitis epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028. Our epidemiology services include: • Incidence and prevalence • Diagnosis rate, treatment rate and mortality patterns • Epidemiology-based forecasting and disease trends • Size of different patient segments in a
Global Ulcerative Colitis Treatment Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Ulcerative Colitis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/323101/global-ulcerative-colitis-treatment-market-insights   Anti-inflammatory drugs are often the first
Ulcerative Colitis Market and Forecast Analysis
Boston, MA ReportsWorldwide has announced the addition of a new report title Ulcerative Colitis Market and Forecast Analysis to its growing collection of premium market research reports. Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inappropriate diffuse inflammation of the rectal and colonic mucosa, which occurs in the innermost layer of the intestinal lining. Ulcerative colitis is a chronic, incurable disease with low mortality that is generally diagnosed
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained